Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.
Why should you use Isotype Control Antibodies – MBL
![Why should you use Isotype Control Antibodies – MBL Why should you use Isotype Control Antibodies – MBL](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/file-2138046676-1.jpg)
Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.
To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.
ProSci has 25+ years expertise in developing antibodies. This white paper details use of RIPK antibodies & findings on RIPKs in signalling pathways.
ProSci has 25+ years of expertise in developing antibodies. This white paper details use of ProSci antibodies in the study of programmed cell death.
ProSci details the importance of PD-1 antibodies are important in resolving complex interactions between the immune system & pathological conditions.